Vatelizumab (GBR500) is a monoclonal antibody that targets the alpha2 subunit (CD49b) of very late antigen 2 (VLA-2). Vatelizumab can be used for research on multiple sclerosis[1].
Molecular Weight:
(144.28 kDa)
Purity:
99.90
CAS Number:
[1238217-55-4]
Target:
Integrin
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted
